| Titre : | Étude in silico d’inhibiteurs du récepteur EGFR ciblant les mutations associées à la résistance thérapeutique dans le cancer du poumon |
| Auteurs : | Selsabil KADDOUR, Directeur de thèse ; Faiza Lehraki, Auteur |
| Type de document : | Mémoire magistere |
| Editeur : | Biskra [Algérie] : Faculté des Sciences Exactes et des Sciences de la Nature et de la Vie, Université Mohamed Khider, 2026 |
| Format : | 1VOL.(62) |
| Langues: | Anglais |
| Langues originales: | Anglais |
| Mots-clés: | Key word: NSCLC, EGFR, L858R/T790M/C797S, Osimertinib, molecular docking. |
| Résumé : |
This in silico investigation highlighted the potential of new 9H-purine derivatives as inhibitors of the triple-mutant EGFR (L858R/T790M/C797S), which is implicated in the development of non-small cell lung cancer (NSCLC). Molecular docking analyses revealed that ligands L21 and L29 (in the presence of water molecules) as well as L16 and L25 (in anhydrous conditions) develop optimal interactions with the critical residues of the active site. At the same time, the examination of their "drug-likeness" profile confirms physicochemical properties favorable for oral administration. These molecules thus represent serious candidates for developing fourth-generation therapies aimed at overcoming resistance associated with EGFR triple mutations. |
Disponibilité (1)
| Cote | Support | Localisation | Statut |
|---|---|---|---|
| MCH/724 | Mémoire master | bibliothèque sciences exactes | Consultable |




